Hopen’s Mike Jandernoa to Receive “Spirit of Michigan” Award at Accelerate Michigan Innovation Competition’s Gala Awards

Dearborn, Mich. (November 10, 2011) The Accelerate Michigan Innovation Competition (AMIC) has announced that its 2011 “Spirit of Michigan” recipient is Mike Jandernoa. Each year a Michigan business person is chosen to receive the award […]

Read On ›

Metabolic Solutions Development Company Receives $1.1 Million NIH Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease

Kalamazoo, Mich. (October 6, 2011) – Metabolic Solutions Development Company, LLC (MSDC) announced today it has received a $1.1 million multi-year Small Business Technology Transfer Program (STTR) grant from the National Institute on Alcohol Abuse […]

Read On ›

Metabolic Solutions Development Company Reports Positive Top-Line Results from Phase 2A Study of its Second Compound to Treat Type 2 Diabetes

Kalamazoo, Mich. (September 08, 2011) – Metabolic Solutions Development Company, LLC (MSDC) confirmed today the potential of MSDC-0602 to achieve significant glucose control in type 2 diabetes patients and increase insulin sensitivity based on preliminary […]

Read On ›

Nymirum’s Hashim M. Al-Hashimi Recognized as “Molecular Filmmaker” in PopSci’s 10th Annual Brilliant 10

Early every morning, before dawn if he can, Hashim Al-Hashimi goes running. Six miles, rain or shine, summer heat or bitter Michigan cold (Al-Hashimi works at the University of Michigan). His chosen route is hilly… […]

Read On ›

Hopen Life Science Ventures Fund II Reaches $25 Million Initial Close and Announces First Four Investments

Grand Rapids, Mich. (August 4, 2011) – Hopen Life Science Ventures, a Grand Rapids-based life science venture capital fund, announced an initial close of $25 million for its second fund, Hopen Life Science Fund II. […]

Read On ›

Two heart-repair device firms pull in $7M

Minnetonka, Minn. (August 4, 2011) – Minnesota companies continue to pull in venture capital, with two multimillion-dollar money raises disclosed in recent U.S. Securities and Exchange Commission filings. Minnetonka-based NeoChord recently raised $5 million and […]

Read On ›

A tale of proteins and cells: Metabolic Solutions is trying to write next chapter with new diabetes, heart treatments – Kalamazoo Gazette

Kalamazoo, Mich. (July 24, 2011) – Metabolic Solutions Development Company was recently featured in the Kalamazoo Gazette putting the spotlight on the company’s efforts to develop novel treatments for metabolic diseases. Read the complete Kalamazoo […]

Read On ›

Investors put $7.2 million into life sciences firm Intervention Insights in Grand Rapids

Grand Rapids, Mich. (July 18, 2011) – The $7.2 million from a group of investors will help Intervention Insightsfurther commercialize a technology that enables oncologists to match cancer patients with drugs that work best on […]

Read On ›

MSDC Receives $773,000 from the Alzheimer’s Drug Discovery Foundation to Fund Phase 2a Trial

Kalamazoo, Mich. (July 06, 2011) – Metabolic Solutions Development Company (MSDC), a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has received a $773,000 grant from […]

Read On ›

MSDC to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference

Kalamazoo, Mich. (June 21, 2011) – Metabolic Solutions Development Company (MSDC) and collaborators will present their research providing insights into the therapeutic potential of increasing brown adipose tissue in the treatment of diabetes and the […]

Read On ›

MSDC Launches Phase 2A Trial of Its Second Compound to Treat Type 2 Diabetes

Kalamazoo, Mich. (March 29, 2011) – Metabolic Solutions Development Company (MSDC), a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial […]

Read On ›